Captor Therapeutics Spolka Akcyjna reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported net loss was PLN 59.1 million compared to PLN 29.38 million a year ago. Basic loss per share from continuing operations was PLN 13.92 compared to PLN 7.05 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
76.4 PLN | -2.05% | -7.95% | -22.83% |
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-22.83% | 88.89M | |
+17.96% | 44.96B | |
+48.77% | 41.85B | |
+1.17% | 42.65B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- CTX Stock
- News Captor Therapeutics Spolka Akcyjna
- Captor Therapeutics Spolka Akcyjna Reports Earnings Results for the Nine Months Ended September 30, 2023